Within the framework of the IAEA Coordinated Analysis Challenge (CRP) J02012 on ‘Advancing Radiation Detection Tools for Detecting Nuclear and Different Radioactive Materials Out of Regulatory Management’, the properties of two industrial devices (1) InSpector 1000 analyzer (Canberra), with a 2″ × 2″ NaI(Tl) scintillator and (2) RIIDEYE M-G3 analyzer (Thermo Scientific), with a 3″ × 3″ NaI(Tl) scintillator, have been evaluated as dosimeters by laboratory and area measurements.
Within the Ionizing Radiation Calibration Laboratory (IRCL) of the Greek Atomic Power Fee, the NaI(Tl) spectrometers have been examined in an effort to measure Ambient gamma Dose Equal Price (ADER). The NaI(Tl) scintillators have been irradiated in a homogeneous area with 662 keV photons with completely different ADER values from 0.17 to 100 μSv h-1 at 0° incidence (irradiation area perpendicular to the detector’s entrance window) and at 90° incidence.
For every irradiation, the measured ADER by the spectrometers and the ‘true’ ADER values (offered by the IRCL) have been in contrast. As well as, the angular dependence (0-359°) of the ADER response of the spectrometers was studied with a 152Eu supply positioned at 1, 2 and three m from the spectrometers. The ADER dependence as perform of the space from the 152Eu supply (at 0° incidence) measured by the 2 detectors was in contrast with the theoretical one.
Within the area research, ADER was measured by the spectrometers at seven areas belonging to the Greek Early Warning System Community (which is predicated on Reuter-Stokes ionization chambers). These areas have completely different ADER values starting from 20 to 120 nSv h-1. In these areas, gamma ADER have been additionally deduced (1) by in situ gamma spectrometry measurements with moveable Germanium HPGe detectors and (2) by the Reuter-Stokes ionization chambers (by subtraction of the cosmic radiation).
Gamma dose measurements have been additionally carried out with the InSpector 1000 and RIIDEYE M-G3 detectors in 25 areas (seashores) of Northern Greece and in contrast with the ADER values deduced by sand pattern evaluation with gamma spectroscopy. Seashores with sand are good candidates for such kind of measurements since they’re generally flat and in precept the pure radionuclides are homogenously distributed.
Design and optimization of a complicated time-of-flight neutron spectrometer for deuterium plasmas of the massive helical system
A time-of-flight neutron spectrometer based mostly on the Time-Of-Flight Enhanced Diagnostic (TOFED) idea has been designed and is beneath improvement for the Massive Helical Gadget (LHD). Will probably be the primary superior neutron spectrometer to measure the two.45 MeV D-D neutrons (DDNs) from helical/stellarator plasmas.
The primary mission of the brand new TOFED is to review the supra-thermal deuterons generated from the auxiliary heating methods in helical plasmas by measuring the time-of-flight spectra of DDN. It can additionally measure the triton burnup neutrons (TBNs) from the d+t reactions, not like the unique TOFED within the EAST tokamak. Its functionality of diagnosing the TBN ratios is evaluated on this work.
This new TOFED is predicted to be put in within the basement beneath the LHD corridor and shares the collimator with one channel of the vertical neutron digital camera to outline its line of sight. The gap from its main scintillators to the equatorial airplane of LHD plasmas is about 15.5 m. Based mostly on Monte Carlo simulation by a GEANT4 mannequin, the decision of the DDN power spectra is 6.6%.
When projected onto the neutron charges which are sometimes obtained in LHD deuterium plasmas (an order of 1015 n/s with impartial beam injection), we count on to acquire the DDN and TBN counting charges of about 2.5 · 105 counts/s and 250 counts/s, respectively. This may permit us to research the DDN time-of-flight spectra on time scales of 0.1 s and diagnose the TBN emission charges in a number of seconds with one instrument, for the primary time in helical/stellarator plasmas.
Cell-phone digital camera Raman spectrometer
On this report, we describe the design, building, and operation of a cell-phone-based Raman and emission spectral detector, which when coupled to a diffraction grating and cell-phone digital camera system supplies means for the detection, recording, and identification of chemical substances, medicine, and organic molecules, in situ via their Raman and fluorescence spectra.
The newly constructed cell-phone spectrometer system was used to report Raman spectra from varied chemical substances and organic molecules together with the resonance enhanced Raman spectra of carrots and micro organism. As well as, we current the quantitative evaluation of alcohol-water Raman spectra, carried out utilizing our cell-phone spectrometer.
The designed and constructed system was additionally used for setting up Raman photos of the samples by using a place scanning stage together with the system. This compact and moveable system is nicely fitted to in situ area purposes of Raman and fluorescence spectroscopy and may additionally be an built-in characteristic of future cell-phones.
Ultrahigh delicate transient absorption spectrometer
Transient absorption (TA) spectroscopy is taken into account as a robust method that displays the ultrafast dynamics of photogenerated carriers in photoelectric and photocatalysis supplies. Nonetheless, restricted by its sensitivity, the photogenerated provider density in TA measurements of photo voltaic power supplies is normally a lot increased than that in the actual working situation.
Right here, we current a mixture of kHz macro-pulse and MHz micro-pulse method for an ultrahigh delicate TA spectrometer, which improves the sensitivity to the 10-7 stage of ΔOD. It allows us to review ultrafast provider dynamics pumped by very low energy, which might keep away from the affect of many-body interactions and the nonlinear impact related to excessive provider density.
Trifluoroacetic acid, Ultrapure for synthesis |
|||
GK2000-1 | Glentham Life Sciences | 1 | EUR 261 |
Trifluoroacetic acid, Ultrapure for synthesis |
|||
GK2000-100 | Glentham Life Sciences | 100 | EUR 39.4 |
TMP-PEG3-amine, trifluoroacetic acid salt |
|||
91056 | Biotium | 1MG | EUR 234 |
Description: Minimum order quantity: 1 unit of 1MG |
N-(6-Aminohexyl)maleimide, trifluoroacetic acid salt: (100mg) |
|||
91051 | Biotium | 100MG | EUR 574.8 |
Description: Minimum order quantity: 1 unit of 100MG |
Biotin-PEO2-PPO2-amine, trifluoroacetic acid salt:10mg |
|||
90078 | Biotium | 10MG | EUR 241.2 |
Description: Minimum order quantity: 1 unit of 10MG |
TRIFLUOROACETIC ANHYDRIDE |
|||
520009 | Survival Technologies | each | Ask for price |
L-Alanine-7-amido-4-methylcoumarin trifluoroacetic acid salt |
|||
GC8079-250 | Glentham Life Sciences | 250 | EUR 172.7 |
L-Alanine-7-amido-4-methylcoumarin trifluoroacetic acid salt |
|||
GC8079-50 | Glentham Life Sciences | 50 | EUR 57 |
ARP (N-(Aminooxyacetyl)-N'-(D-biotinoyl)hydrazine, trifluoroacetic acid salt): (10mg) |
|||
90073 | Biotium | 10MG | EUR 303.6 |
Description: Minimum order quantity: 1 unit of 10MG |
Ro 26-4550 trifluoroacetate |
|||
B5176-10 | ApexBio | 10 mg | EUR 614.4 |
Description: IC50: 3 ?MRo 26-4550 trifluoroacetate is a competitive reversible inhibitor of interleukin-2 (IL-2) binding to its receptor [1]. Interleukin-2 (IL-2) (a 15.5 kDa cytokine) plays a predominant role in the growth of activated T cells. |
GSK 256066 Trifluoroacetate |
|||
HY-70069 | MedChemExpress | 5mg | EUR 291.6 |
PHP 501 trifluoroacetate |
|||
B5608-10 | ApexBio | 10 mg | EUR 517.2 |
PHP 501 trifluoroacetate |
|||
B5608-50 | ApexBio | 50 mg | EUR 1987.2 |
PMX 205 Trifluoroacetate |
|||
HY-110136A | MedChemExpress | 500ug | EUR 224.4 |
RGD Trifluoroacetate |
|||
HY-P0278A | MedChemExpress | 25mg | EUR 391.2 |
BIBP 3226 trifluoroacetate |
|||
B7155-1 | ApexBio | 1 mg | EUR 321.6 |
Description: BIBP 3226 trifluoroacetate is a non-peptide neuropeptide Y Y1 (NPY Y1) and neuropeptide FF (NPFF) receptor antagonist with Ki values of 1.1, 79, 108 for rNPY Y1, hNPFF2, rNPFF, respectively. Neuropeptide Y Y1 receptors (NPY Y1) involve in the regulation of exploratory behaviour and anxiety. |
BIBP 3226 trifluoroacetate |
|||
B7155-10 | ApexBio | 10 mg | EUR 642 |
Description: BIBP 3226 trifluoroacetate is a non-peptide neuropeptide Y Y1 (NPY Y1) and neuropeptide FF (NPFF) receptor antagonist with Ki values of 1.1, 79, 108 for rNPY Y1, hNPFF2, rNPFF, respectively. Neuropeptide Y Y1 receptors (NPY Y1) involve in the regulation of exploratory behaviour and anxiety. |
BIBO 3304 trifluoroacetate |
|||
B7047-10 | ApexBio | 10 mg | EUR 654 |
Description: BIBO 3304 is a high affinity NPY Y1 receptor antagonist with IC50 values of 0.72 and 0.38 nM at rat and human receptors respectively [1].Neuropeptide Y is a 36 amino acid polypeptide that is expressed in the hypothalamus. |
BIBO 3304 trifluoroacetate |
|||
B7047-50 | ApexBio | 50 mg | EUR 2563.2 |
Description: BIBO 3304 is a high affinity NPY Y1 receptor antagonist with IC50 values of 0.72 and 0.38 nM at rat and human receptors respectively [1].Neuropeptide Y is a 36 amino acid polypeptide that is expressed in the hypothalamus. |
L-803,087 trifluoroacetate |
|||
B6904-10 | ApexBio | 10 mg | EUR 633.6 |
ARRY 520 trifluoroacetate |
|||
A4458-10 | ApexBio | 10 mg | EUR 393.6 |
Description: ARRY 520 trifluoroacetate is a synthetic and salt form of KSP inhibitor with IC50 value of 6 nM. Kinesin spindle protein (KSP) is one member of the mitotic kinesins involved in the early stages of mitosis responsible for centrosome separation. |
ARRY 520 trifluoroacetate |
|||
A4458-25 | ApexBio | 25 mg | EUR 790.8 |
Description: ARRY 520 trifluoroacetate is a synthetic and salt form of KSP inhibitor with IC50 value of 6 nM. Kinesin spindle protein (KSP) is one member of the mitotic kinesins involved in the early stages of mitosis responsible for centrosome separation. |
ARRY 520 trifluoroacetate |
|||
A4458-5 | ApexBio | 5 mg | EUR 247.2 |
Description: ARRY 520 trifluoroacetate is a synthetic and salt form of KSP inhibitor with IC50 value of 6 nM. Kinesin spindle protein (KSP) is one member of the mitotic kinesins involved in the early stages of mitosis responsible for centrosome separation. |
ARRY 520 trifluoroacetate |
|||
A4458-100 | ApexBio | 100mg | EUR 2456 |
Description: KSP inhibitor |
ARRY 520 trifluoroacetate |
|||
A4458-50 | ApexBio | 50mg | EUR 1455 |
Description: KSP inhibitor |
TRIFLUOROACETAMIDE |
|||
920012 | Survival Technologies | each | Ask for price |
ALX 40-4C Trifluoroacetate |
|||
HY-P7061A | MedChemExpress | 5mg | EUR 1230 |
ADH-1 trifluoroacetate |
|||
HY-13541A | MedChemExpress | 10mM/1mL | EUR 333.6 |
SB 290157 (trifluoroacetate salt) |
|||
C3563-10 | ApexBio | 10 mg | EUR 247.2 |
Description: IC50: 200 nMSB 290157 is a C3aR antagonist.The anaphylatoxin C3a, a potent chemotactic peptide and inflammatory mediator, binds to and activates a G-protein-coupled receptor. |
SB 290157 (trifluoroacetate salt) |
|||
C3563-25 | ApexBio | 25 mg | EUR 454.8 |
Description: IC50: 200 nMSB 290157 is a C3aR antagonist.The anaphylatoxin C3a, a potent chemotactic peptide and inflammatory mediator, binds to and activates a G-protein-coupled receptor. |
SB 290157 (trifluoroacetate salt) |
|||
C3563-5 | ApexBio | 5 mg | EUR 176.4 |
Description: IC50: 200 nMSB 290157 is a C3aR antagonist.The anaphylatoxin C3a, a potent chemotactic peptide and inflammatory mediator, binds to and activates a G-protein-coupled receptor. |
PPACK II, trifluoroacetate |
|||
B2151-5 | Biovision | each | EUR 352.8 |
4-(Trifluoroacetyl)toluene |
|||
20-abx183477 | Abbexa |
|
|
Methyl trifluoroacetate |
|||
20-abx184730 | Abbexa |
|
|
GSK-121 trifluoroacetate |
|||
B1034-1000 | Biovision | each | EUR 222 |
GSK-121 trifluoroacetate |
|||
B1034-500 | Biovision | each | EUR 157.2 |
AT7519 trifluoroacetate |
|||
A3198-10 | ApexBio | 10 mg | EUR 223.2 |
Description: AT7519 is a kinase inhibitor with IC50 of 0.19, 0.044, 0.51, 0.067, 0.66 and 0.018 ?M for CDK1/cyclinB, CDK2/CyclinA, CDK2/Cyclin E, CDk4/CyclinD1, CDK6/Cyclin D3, CDk5/p35. |
AT7519 trifluoroacetate |
|||
A3198-100 | ApexBio | 100 mg | EUR 512.4 |
Description: AT7519 is a kinase inhibitor with IC50 of 0.19, 0.044, 0.51, 0.067, 0.66 and 0.018 ?M for CDK1/cyclinB, CDK2/CyclinA, CDK2/Cyclin E, CDk4/CyclinD1, CDK6/Cyclin D3, CDk5/p35. |
AT7519 trifluoroacetate |
|||
A3198-5 | ApexBio | 5 mg | EUR 166.8 |
Description: AT7519 is a kinase inhibitor with IC50 of 0.19, 0.044, 0.51, 0.067, 0.66 and 0.018 ?M for CDK1/cyclinB, CDK2/CyclinA, CDK2/Cyclin E, CDk4/CyclinD1, CDK6/Cyclin D3, CDk5/p35. |
AT7519 trifluoroacetate |
|||
A3198-50 | ApexBio | 50 mg | EUR 404.4 |
Description: AT7519 is a kinase inhibitor with IC50 of 0.19, 0.044, 0.51, 0.067, 0.66 and 0.018 ?M for CDK1/cyclinB, CDK2/CyclinA, CDK2/Cyclin E, CDk4/CyclinD1, CDK6/Cyclin D3, CDk5/p35. |
AT7519 (trifluoroacetate) |
|||
HY-50940A | MedChemExpress | 50mg | EUR 321.6 |
MK-8245 (Trifluoroacetate) |
|||
HY-13077 | MedChemExpress | 50mg | EUR 878.4 |
Silver trifluoroacetate, 97+% |
|||
GX7211-25 | Glentham Life Sciences | 25 | EUR 277.1 |
Silver trifluoroacetate, 97+% |
|||
GX7211-5 | Glentham Life Sciences | 5 | EUR 114.5 |
Sodium trifluoroacetate, 97+% |
|||
GX3440-50 | Glentham Life Sciences | 50 | EUR 123.5 |
GSK2807 Trifluoroacetate |
|||
HY-104009A | MedChemExpress | 100mg | EUR 2264.4 |
XMD-17-51 Trifluoroacetate |
|||
HY-117291A | MedChemExpress | 10mM/1mL | EUR 453.6 |
GGTI298 Trifluoroacetate |
|||
HY-15871 | MedChemExpress | 25mg | EUR 817.2 |
2,4,6-Trifluoroacetophenone |
|||
20-abx182978 | Abbexa |
|
|
3-Bromo-1,1,1-trifluoroacetone |
|||
20-abx183344 | Abbexa |
|
|
NGR peptide Trifluoroacetate |
|||
HY-P1043A | MedChemExpress | 5mg | EUR 555.6 |
Cyclo(RGDyK) trifluoroacetate |
|||
HY-100563 | MedChemExpress | 10mM/1mL | EUR 291.6 |
SB290157 (trifluoroacetate) |
|||
HY-101502A | MedChemExpress | 50mg | EUR 538.8 |
Bestatin (trifluoroacetate) |
|||
HY-B0134B | MedChemExpress | 50mg | EUR 357.6 |
ATN-161 (trifluoroacetate salt) |
|||
HY-13535A | MedChemExpress | 10mg | EUR 280.8 |
N-(Trifluoroacetyl) Imidazole |
|||
42000076-1 | Bio-WORLD | 5 mL | EUR 104.31 |
1,1,1-Trifluoroacetylacetone |
|||
20-abx182816 | Abbexa |
|
|
Palladium(II) trifluoroacetate |
|||
20-abx186081 | Abbexa |
|
|
PPACKII (trifluoroacetate salt) |
|||
C3393-10 | ApexBio | 10 mg | EUR 423.6 |
Description: PPACKII is a specific and irreversible inhibitor of glandular and plasma kallikreins [1]. Human tissue kallikreins (hKs) are a class of secreted serine proteases that involved in the release of vasodepressor peptides or kinins from a plasma substrate. |
PPACKII (trifluoroacetate salt) |
|||
C3393-25 | ApexBio | 25 mg | EUR 908.4 |
Description: PPACKII is a specific and irreversible inhibitor of glandular and plasma kallikreins [1]. Human tissue kallikreins (hKs) are a class of secreted serine proteases that involved in the release of vasodepressor peptides or kinins from a plasma substrate. |
PPACKII (trifluoroacetate salt) |
|||
C3393-5 | ApexBio | 5 mg | EUR 265.2 |
Description: PPACKII is a specific and irreversible inhibitor of glandular and plasma kallikreins [1]. Human tissue kallikreins (hKs) are a class of secreted serine proteases that involved in the release of vasodepressor peptides or kinins from a plasma substrate. |
LL-37 (human) trifluoroacetate salt |
|||
L046-1MG | TOKU-E | 1 mg | EUR 205.2 |
Pepstatin Trifluoroacetate |
|||
HY-P0018A | MedChemExpress | 10mM/1mL | EUR 135.6 |
c-Myc Peptide Trifluoroacetate |
|||
HY-P0312 | MedChemExpress | 10mg | EUR 523.2 |
EPZ011989 (trifluoroacetate) |
|||
HY-16986A | MedChemExpress | 50mg | EUR 445.2 |
UNC0321 tri(trifluoroacetate salt) |
|||
B2837-1 | Biovision | each | EUR 130.8 |
UNC0321 tri(trifluoroacetate salt) |
|||
B2837-5 | Biovision | each | EUR 314.4 |
F-Amidine (trifluoroacetate salt) |
|||
B2803-100 | Biovision | each | EUR 157.2 |
F-Amidine (trifluoroacetate salt) |
|||
B2803-500 | Biovision | each | EUR 418.8 |
Dolastatin 10 trifluoroacetate |
|||
B1066-1 | ApexBio | 1 mg | EUR 787.2 |
Description: Dolastatin 10 trifluoroacetate is an antitumor agent [1].Dolastatin 10 trifluoroacetate is a potent antimitotic polypeptide isolated from a marine animal and is developed as a potential antitumor agent. |
Dolastatin 10 trifluoroacetate |
|||
B1066-5 | ApexBio | 5 mg | EUR 2043.6 |
Description: Dolastatin 10 trifluoroacetate is an antitumor agent [1].Dolastatin 10 trifluoroacetate is a potent antimitotic polypeptide isolated from a marine animal and is developed as a potential antitumor agent. |
Taltobulin trifluoroacetate |
|||
ADC-P-028 | Creative Biolabs | unit | Ask for price |
PYRIDINIUM TRIFLUOROACETATE |
|||
516009 | Survival Technologies | each | Ask for price |
Vandetanib (trifluoroacetate) |
|||
HY-10260A | MedChemExpress | 100mg | EUR 357.6 |
Taltobulin (trifluoroacetate) |
|||
HY-15584A | MedChemExpress | 50mg | EUR 1368 |
Rapastinel (Trifluoroacetate) |
|||
HY-16728B | MedChemExpress | 10mM/1mL | EUR 396 |
Cl-Amidine (trifluoroacetate salt) |
|||
C3829-10 | ApexBio | 10 mg | EUR 325.2 |
Description: IC50: 5.9 ?MCl-Amidine is a PAD4 deimination activity inhibitor.Protein arginine deiminase 4 (PAD4) can catalyze the post-translational modification of arginine residues on histones to form citrulline, which can change gene expression. |
Cl-Amidine (trifluoroacetate salt) |
|||
C3829-5 | ApexBio | 5 mg | EUR 226.8 |
Description: IC50: 5.9 ?MCl-Amidine is a PAD4 deimination activity inhibitor.Protein arginine deiminase 4 (PAD4) can catalyze the post-translational modification of arginine residues on histones to form citrulline, which can change gene expression. |
VU0364572 (trifluoroacetate salt) |
|||
C4396-1 | ApexBio | 1 mg | EUR 138 |
Description: IC50: 477 ± 172 nMVU0364572 is a M1 agonist.Alzheimer's disease (AD) is the leading cause of dementia worldwide, and no disease-modifying therapy is availables. |
VU0364572 (trifluoroacetate salt) |
|||
C4396-10 | ApexBio | 10 mg | EUR 687.6 |
Description: IC50: 477 ± 172 nMVU0364572 is a M1 agonist.Alzheimer's disease (AD) is the leading cause of dementia worldwide, and no disease-modifying therapy is availables. |
VU0364572 (trifluoroacetate salt) |
|||
C4396-25 | ApexBio | 25 mg | EUR 1434 |
Description: IC50: 477 ± 172 nMVU0364572 is a M1 agonist.Alzheimer's disease (AD) is the leading cause of dementia worldwide, and no disease-modifying therapy is availables. |
VU0364572 (trifluoroacetate salt) |
|||
C4396-5 | ApexBio | 5 mg | EUR 414 |
Description: IC50: 477 ± 172 nMVU0364572 is a M1 agonist.Alzheimer's disease (AD) is the leading cause of dementia worldwide, and no disease-modifying therapy is availables. |
Bivalirudin Trifluoroacetate |
|||
A3244-100 | ApexBio | 100 mg | EUR 234 |
Description: BivalirudinTrifluoroacetate is a specific, reversible and direct thrombin inhibitor with a predictable anticoagulant effect.In patients with normal or mildly impaired renal function, bivalirudin exihibited several notable mechanistic advantages when compared with unfractionated heparin. |
Bivalirudin Trifluoroacetate |
|||
A3244-500 | ApexBio | 500 mg | EUR 584.4 |
Description: BivalirudinTrifluoroacetate is a specific, reversible and direct thrombin inhibitor with a predictable anticoagulant effect.In patients with normal or mildly impaired renal function, bivalirudin exihibited several notable mechanistic advantages when compared with unfractionated heparin. |
Gardiquimod trifluoroacetate |
|||
HY-103697A | MedChemExpress | 100mg | EUR 721.2 |
4-Nitrophenyl trifluoroacetate |
|||
20-abx183638 | Abbexa |
|
|
N-[2-Iodoethyl]trifluoroacetamide |
|||
20-abx180835 | Abbexa |
|
|
4-(Trifluoroacetyl)benzoyl chloride |
|||
GW0017-1 | Glentham Life Sciences | 1 | EUR 123.3 |
4-(Trifluoroacetyl)benzoyl chloride |
|||
GW0017-5 | Glentham Life Sciences | 5 | EUR 208.7 |
V5 Epitope Tag Peptide Trifluoroacetate |
|||
HY-P0325 | MedChemExpress | 10mg | EUR 408 |
5-ROX Cadaverine Trifluoroacetate salt |
|||
91060 | Biotium | 1MG | EUR 220 |
Description: N/A |
Phe-Met-Arg-Phe amide trifluoroacetate |
|||
HY-P0249A | MedChemExpress | 25mg | EUR 374.4 |
biotin cadaverine, trifluoroacetate salt |
|||
90063 | Biotium | 50MG | EUR 225.6 |
Description: Minimum order quantity: 1 unit of 50MG |
6-TAMRA Cadaverine, Trifluoroacetate Salt |
|||
90122 | Biotium | 1MG | EUR 129 |
Description: N/A |
Bis(trimethylsilyl)trifluoroacetamide |
|||
GK7139-25 | Glentham Life Sciences | 25 | EUR 40.9 |
Bis(trimethylsilyl)trifluoroacetamide |
|||
GK7139-5 | Glentham Life Sciences | 5 | EUR 21.4 |
N,O-Bis(Trimethylsilyl)Trifluoroacetamide |
|||
20-abx188805 | Abbexa |
|
|
N,O-Bis(trimethylsilyl)trifluoroacetamide |
|||
05102-04 | NACALAI TESQUE | 10ML | EUR 119 |
N,O-Bis(trimethylsilyl)trifluoroacetamide |
|||
05102-91 | NACALAI TESQUE | 1ML | EUR 27.3 |
4-Amino-2-piperidinone trifluoroacetate |
|||
20-abx180494 | Abbexa |
|
|
Biotin-X cadaverine, trifluoroacetate salt: (20mg) |
|||
90061 | Biotium | 20MG | EUR 225.6 |
Description: Minimum order quantity: 1 unit of 20MG |
Carboxy pyridostatin trifluoroacetate salt |
|||
HY-112680A | MedChemExpress | 5mg | EUR 542.4 |
N,O‐BIS‐(TRIMETHYLSILYL) TRIFLUOROACETAMIDE (BSTFA) |
|||
902006 | Survival Technologies | each | Ask for price |
Lactoferricin B fragment 4-14 trifluoroacetate salt |
|||
L043-1MG | TOKU-E | 1 mg | EUR 238.8 |
4-pentynoyl-Coenzyme A (trifluoroacetate salt) |
|||
B2838-1000 | Biovision | each | EUR 379.2 |
4-pentynoyl-Coenzyme A (trifluoroacetate salt) |
|||
B2838-500 | Biovision | each | EUR 235.2 |
Bis(trimethylsilyl)trifluoroacetamide with 1% TMCS |
|||
GK0113-1G | Glentham Life Sciences | 1 g | EUR 50.4 |
Bis(trimethylsilyl)trifluoroacetamide with 1% TMCS |
|||
GK0113-1 | Glentham Life Sciences | 1 | EUR 13 |
Octreotide trifluoroacetate salt (Dimer, Parallel) |
|||
H-7374.0500 | Bachem | 0.5mg | EUR 480 |
Description: Sum Formula: C98H132N20O20S4; CAS# [1926163-80-5] net |
Octreotide trifluoroacetate salt (Dimer, Parallel) |
|||
H-7374.1000 | Bachem | 1.0mg | EUR 776.4 |
Description: Sum Formula: C98H132N20O20S4; CAS# [1926163-80-5] net |
N-Methyl-N-(trimethylsilyl)trifluoroacetamide |
|||
GK6777-100 | Glentham Life Sciences | 100 | EUR 310.3 |
N-Methyl-N-(trimethylsilyl)trifluoroacetamide |
|||
GK6777-25 | Glentham Life Sciences | 25 | EUR 112.3 |
N-Methyl-N-(trimethylsilyl)trifluoroacetamide |
|||
GK6777-5 | Glentham Life Sciences | 5 | EUR 37.7 |
1,3-Diethyl2-(2,2,2-trifluoroacetamido)propanedioate |
|||
20-abx186125 | Abbexa |
|
|
2-Sulforhodamine 101 cadaverine, trifluoroacete salt |
|||
90115 | Biotium | 5MG | EUR 410.4 |
Description: Minimum order quantity: 1 unit of 5MG |
4-Sulforhodamine 101 cadaverine, trifluoroacete salt |
|||
90116 | Biotium | 5MG | EUR 410.4 |
Description: Minimum order quantity: 1 unit of 5MG |
N-(6-Aminohexyl)rhodamine 6G-amide bis(trifluoroacetate) |
|||
GW7025-10 | Glentham Life Sciences | 10 | EUR 161.8 |
N-(6-Aminohexyl)rhodamine 6G-amide bis(trifluoroacetate) |
|||
GW7025-50 | Glentham Life Sciences | 50 | EUR 405.4 |
Octreotide trifluoroacetate salt (Dimer, Antiparallel) |
|||
H-7376.0500 | Bachem | 0.5mg | EUR 480 |
Description: Sum Formula: C98H132N20O20S4; CAS# [1926163-78-1] net |
Octreotide trifluoroacetate salt (Dimer, Antiparallel) |
|||
H-7376.1000 | Bachem | 1.0mg | EUR 776.4 |
Description: Sum Formula: C98H132N20O20S4; CAS# [1926163-78-1] net |
Rhodamine 6G p-diaminoxylene amide bis (trifluoroacetate) |
|||
GW3287-250 | Glentham Life Sciences | 250 | EUR 793.5 |
Rhodamine 6G p-diaminoxylene amide bis (trifluoroacetate) |
|||
GW3287-50 | Glentham Life Sciences | 50 | EUR 252.7 |
Rhodamine 6G bis(aminoethyl)amine amide bis (trifluoroacetate) |
|||
GW3542-250 | Glentham Life Sciences | 250 | EUR 786.5 |
Rhodamine 6G bis(aminoethyl)amine amide bis (trifluoroacetate) |
|||
GW3542-50 | Glentham Life Sciences | 50 | EUR 251.3 |
Rhodamine 6G ethylenediamine amide bis (trifluoroacetate) |
|||
GW3583-10 | Glentham Life Sciences | 10 | EUR 161.8 |
Rhodamine 6G ethylenediamine amide bis (trifluoroacetate) |
|||
GW3583-50 | Glentham Life Sciences | 50 | EUR 405.4 |
Rhodamine 6G bis(oxyethylamino)ethane amide bis (trifluoroacetate) |
|||
GW0572-250 | Glentham Life Sciences | 250 | EUR 786.5 |
Rhodamine 6G bis(oxyethylamino)ethane amide bis (trifluoroacetate) |
|||
GW0572-50 | Glentham Life Sciences | 50 | EUR 251.3 |
N-(tert-Butyldimethylsilyl)-N-methyl trifluoroacetamide |
|||
GK4999-10 | Glentham Life Sciences | 10 | EUR 110.7 |
N-(tert-Butyldimethylsilyl)-N-methyl trifluoroacetamide |
|||
GK4999-25 | Glentham Life Sciences | 25 | EUR 221.5 |
N-(tert-Butyldimethylsilyl)-N-methyl trifluoroacetamide |
|||
GK4999-5 | Glentham Life Sciences | 5 | EUR 67.2 |
Fluorescein cadaverine (5-((5-aminopentyl) thioureidyl)fluorescein, trifluoroacetate salt): (25mg) |
|||
92000 | Biotium | 25MG | EUR 276 |
Description: Minimum order quantity: 1 unit of 25MG |
2-(Trifluoromethyl)-3,3,3-trifluoropropionic acid |
|||
abx181620-1g | Abbexa | 1 g | EUR 276 |
2,3,4-Trifluorobenzoic acid |
|||
GK5123-25 | Glentham Life Sciences | 25 | EUR 118.7 |
2,3,4-Trifluorobenzoic acid |
|||
GK5123-5 | Glentham Life Sciences | 5 | EUR 31.7 |
2,4,5‐TRIFLUOROPHENYLACETIC ACID |
|||
920016 | Survival Technologies | each | Ask for price |
Trifluoromethanesulfonic acid |
|||
abx184793-500g | Abbexa | 500 g | EUR 460.8 |
TRIFLUOROMETHANESULFONIC ACID |
|||
1020004 | Survival Technologies | each | Ask for price |
Trifluoromethanesulfonic acid |
|||
GC7093-10G | Glentham Life Sciences | 10 g | EUR 66 |
Trifluoromethanesulfonic acid |
|||
GC7093-25G | Glentham Life Sciences | 25 g | EUR 96 |
Trifluoromethanesulfonic acid |
|||
GC7093-10 | Glentham Life Sciences | 10 | EUR 24.8 |
Trifluoromethanesulfonic acid |
|||
GC7093-25 | Glentham Life Sciences | 25 | EUR 49.4 |
2-(Trifluoromethyl)Benzoic Acid |
|||
abx188160-250g | Abbexa | 250 g | EUR 1279.2 |
2-(Trifluoromethoxy)benzoic acid |
|||
20-abx185701 | Abbexa |
|
|
2,4,5-Trifluoro-3-methylbenzoic acid |
|||
20-abx182971 | Abbexa |
|
|
2,4,6-Trifluorobenzeneboronic Acid |
|||
20-abx182979 | Abbexa |
|
|
3,3,3-Trifluoro-2,2-dimethylpropionic acid |
|||
20-abx181855 | Abbexa |
|
|
3-Bromo-2,4,5-Trifluorobenzoic Acid |
|||
abx188353-100g | Abbexa | 100 g | EUR 1296 |
2,5‐BIS(2,2,2‐TRIFLUOROETHOXY)BENZOIC ACID |
|||
502020 | Survival Technologies | each | Ask for price |
3-Chloro-2,4,5-trifluorobenzoic acid |
|||
20-abx181930 | Abbexa |
|
|
4-(Trifluoromethyl)Phenylboronic Acid |
|||
20-abx180473 | Abbexa |
|
|
P-(Trifluoromethoxy)Phenylboronic Acid |
|||
20-abx182615 | Abbexa |
|
|
4-(1-Azi-2,2,2-trifluoroethyl)benzoic acid |
|||
Q-1540.0025 | Bachem | 25.0mg | EUR 907.2 |
Description: Sum Formula: C9H5F3N2O2; CAS# [85559-46-2] |
4-(1-Azi-2,2,2-trifluoroethyl)benzoic acid |
|||
Q-1540.0100 | Bachem | 100.0mg | EUR 2648.4 |
Description: Sum Formula: C9H5F3N2O2; CAS# [85559-46-2] |
Benzenepropanoic acid,4-(trifluoromethyl)- |
|||
20-abx182372 | Abbexa |
|
|
Benzenepropanoic acid,2-(trifluoromethyl)- |
|||
20-abx183870 | Abbexa |
|
|
Acetic acid,2,2,2-trifluoro-, aluminum salt (3:1) |
|||
20-abx182362 | Abbexa |
|
|
4-Methyl-3-(trifluoromethyl)benzoic acid |
|||
20-abx183624 | Abbexa |
|
|
3-(3-Trifluoromethylphenyl)propionic acid |
|||
20-abx183273 | Abbexa |
|
|
4'-(Trifluoromethyl)-4-Biphenylboronic Acid |
|||
20-abx185167 | Abbexa |
|
|
3,5-Bis(Trifluoromethyl)Benzeneboronic Acid |
|||
20-abx185757 | Abbexa |
|
|
4-Hydroxy-3-(Trifluoromethyl)Benzoic Acid |
|||
20-abx183603 | Abbexa |
|
|
2-Fluoro-5-(Trifluoromethoxy)Benzoic Acid |
|||
20-abx187886 | Abbexa |
|
|
2-Chloro-6-(trifluoromethyl)nicotinic acid |
|||
20-abx181781 | Abbexa |
|
|
(S)-3,3,3-Trifluoro-2-Hydroxy-2-Methylpropionic Acid |
|||
20-abx180937 | Abbexa |
|
|
(5-Trifluoromethyl-pyridin-2-yl)-acetic acid |
|||
abx182712-1g | Abbexa | 1 g | EUR 727.2 |
This work supplies a novel TA technique with ultrahigh sensitivity, which is able to play an vital function in investigating the provider dynamics of semiconductors within the working situation.